Opin vísindi

RNA sequencing suggests that non-coding RNAs play a role in the development of acquired haemophilia

RNA sequencing suggests that non-coding RNAs play a role in the development of acquired haemophilia


Titill: RNA sequencing suggests that non-coding RNAs play a role in the development of acquired haemophilia
Höfundur: Tigu, Adrian Bogdan
Hotea, Ionut
Drula, Rares
Zimta, Alina Andreea
Dirzu, Noemi
Santa, Maria
Constantinescu, Catalin
Dima, Delia
Bergþórsson, Jón Þór
Greiff, Victor
... 5 fleiri höfundar Sýna alla höfunda
Útgáfa: 2023-07
Tungumál: Enska
Umfang: 7
Deild: Other departments
Faculty of Medicine
Birtist í: Journal of Cellular and Molecular Medicine; 27(13)
ISSN: 1582-1838
DOI: 10.1111/jcmm.17741
Efnisorð: Náttúrufræðingar; acquired haemophilia; coagulation; epigenetics; factor VIII; RNA sequencing; Sequence Analysis, RNA; Humans; RNA, Untranslated; Hemophilia A/genetics; Factor VIII/genetics; Hemorrhage; Molecular Medicine; Cell Biology
URI: https://hdl.handle.net/20.500.11815/4379

Skoða fulla færslu

Tilvitnun:

Tigu , A B , Hotea , I , Drula , R , Zimta , A A , Dirzu , N , Santa , M , Constantinescu , C , Dima , D , Bergþórsson , J Þ , Greiff , V , Gulei , D , Coriu , D , Serban , M , Mahlangu , J & Tomuleasa , C 2023 , ' RNA sequencing suggests that non-coding RNAs play a role in the development of acquired haemophilia ' , Journal of Cellular and Molecular Medicine , vol. 27 , no. 13 , pp. 1790-1796 . https://doi.org/10.1111/jcmm.17741

Útdráttur:

Acquired haemophilia (AH) is a rare disorder characterized by bleeding in patients with no personal or family history of coagulation/clotting-related diseases. This disease occurs when the immune system, by mistake, generates autoantibodies that target FVIII, causing bleeding. Small RNAs from plasma collected from AH patients (n = 2), mild classical haemophilia (n = 3), severe classical haemophilia (n = 3) and healthy donors (n = 2), for sequencing by Illumina, NextSeq500. Based on bioinformatic analysis, AH patients were compared to all experimental groups and a significant number of altered transcripts were identified with one transcript being modified compared to all groups at fold change level. The Venn diagram shows that haemoglobin subunit alpha 1 was highlighted to be the common upregulated transcript in AH compared to classical haemophilia and healthy patients. Non-coding RNAs might play a role in AH pathogenesis; however, due to the rarity of HA, the current study needs to be translated on a larger number of AH samples and classical haemophilia samples to generate more solid data that can confirm our findings.

Athugasemdir:

Funding Information: Adrian Bogdan Tigu and Ionut Hotea contributed equally to the current manuscript and are both considered first author. The authors also gratefully acknowledge the support of Sergiu Pasca, M.D. – Johns Hopkins University School of Medicine, Baltimore, United States, for his contribution on the statistical analysis. Funding Information: IH is funded by an internal grant of the Iuliu Hatieganu University – School of Doctoral Studies. BT is supported by a national grant of the Romanian Academy of Scientists (Academia Oamenilor de Stiinta din Romania) 2023–2024. ABT, DG, JTB and VG are supported by an international collaborative grant of the European Economic Space between Romania and Iceland 2021–2023: ‘Cooperation strategy for knowledge transfer, internationalization and curricula innovation in the field of research education at the 3rd level of study –AURORA.’. The experiments were funded by an international grant awarded by the Novo Nordisk Haemophilia Foundation to the Romanian Haematology Society—Romania 4. CT is supported by a grant by grants awarded by the Romanian National Ministry of 350 Research, Innovation, and Digitalisation: Project PN‐III‐P4‐ID‐PCE‐2020‐1118. Publisher Copyright: © 2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. © 2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Skrár

Þetta verk birtist í eftirfarandi safni/söfnum: